X
Get new exclusive access to healthcare business reports & breaking news
Pharma
Pfizer has announced its intention to purchase Seagen for a whopping $43 billion in order to further its ...
Sanofi SA, the renowned French drugmaker, has announced its plans to shell out a staggering $2.9 billion to ...
Merck & Co. Inc.’s experimental TIGIT drug, vibostolimab, failed to meet its primary endpoint in a Phase 2 ...
Although Ipsen’s Palovarotene was rejected by the FDA just three months ago, the rare disease candidate’s story is ...
Last week proved to be a challenging one for Sangamo Therapeutics. The gene-based therapy biotech company recently announced ...
In response to relentless pressure from diabetes advocates and impending federal legislation limiting Medicare copayments for insulin, Big ...
It’s widely acknowledged nowadays that social media is an incredibly powerful channel for reaching, engaging, and converting a ...
In 2017, former President Donald Trump’s administration passed a business-friendly tax reform that enabled some of the top ...
Berlin-based healthtech, doctorly, has raised $10m for its series A round from WELL Health Technologies and Horizons Ventures, ...
